The World Health Organization (WHO) has issued a significant new recommendation endorsing the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs as an effective treatment option for obesity. This development marks a pivotal moment in global public health efforts to address the escalating obesity crisis,…